FDA Adverse Event
Injury
Summary report: N
OVITEX REINFORCED BIOSCAFFOLD
MDR report key: 10148826
·
Received June 12, 2020
Report
- Report Number
- 3010513348-2020-00003
- Event Type
- Injury
- Date Received
- June 12, 2020
- Date of Event
- May 20, 2020
- Report Date
- June 12, 2020
- Manufacturer
- AROA BIOSURGERY
- Product Code
- FTM
- UDI-DI
- 09421904065093
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
GIVEN THE CULTURE RESULTS, IT IS LIKELY THAT THE BACTERIA ORIGINATED FROM BOTH THE ISCHEMIC BOWEL AND THE SKIN.
Description of Event or Problem · 1
OVITEX 1SP WAS USED TO ROBOTICALLY REPAIR AN UMBILICAL HERNIA CONTAINING TWO BOWEL LOOPS, ONE OF WHICH WAS INCARCERATED CAUSING BOWEL OBSTRUCTION AND BOWEL ISCHEMIA. THE DEVICE WAS INTRODUCED THROUGH THE INCISION SITE. APPROXIMATELY ONE WEEK LATER, THE WOUND BECAME RED AND AN ABSCESS FORMED BETWEEN THE OVITEX AND THE ABDOMINAL WALL. THE SURGEON STARTED ANTIBIOTICS, INCISED THE ABSCESS AND REMOVED THE DEVICE. CULTURES WERE POSITIVE FOR E. COLI AND STREPTOCOCCUS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 611271 | OVITEX REINFORCED BIOSCAFFOLD | SURGICAL MESH | FTM | AROA BIOSURGERY | F10246-1012P | ERT-9A06 | 09421904065093 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |